Platinum Nanocatalyst Could Aid Drugmakers
Main Category: Biology / BiochemistryAlso Included In: Pharma Industry / Biotech Industry
Article Date: 01 Sep 2009 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call this week with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers.
The research is available online in the Sept. 1 issue of the German scientific journal Angewandte Chemie International Edition.
Catalysts are compounds that speed up or slow down chemical reactions without being consumed by them. An everyday example would be the catalytic converters that help breakdown toxic components of automotive exhaust. The chemical and drug industries spend billions of dollars each year for catalysts that are needed to process drugs and other high-value chemicals.
"There are some industrial reactions where drugmakers have no choice but to use platinum and palladium catalysts, but the majority of these are homogenous, which means they mix readily with reactants and are very difficult to remove," said lead researcher Eugene Zubarev, associate professor in chemistry at Rice. "Because these heavy metals are toxic, they must be completely removed from the drug after its synthesis is completed. However, the removal of homogeneous catalysts is very time-consuming and expensive, which creates a big problem for pharmaceutical companies."
Among catalysts, platinum and palladium are prized for reactions involving hydrogen because atoms of hydrogen typically join together in pairs, and platinum and palladium are particularly good at cleaving these pairs and leaving the individual hydrogen atoms available for reactions with other molecules.
Zubarev and Rice graduate student Bishnu Khanal, who will soon start his postdoctoral research at Los Alamos National Laboratory, set out to make a heterogeneous platinum catalyst that was soluble enough for industrial use, but that could also be easily removed.
Previous studies had shown that combining platinum with gold in tiny nanoparticles could enhance the platinum's catalytic effect, so Zubarev and Khanal started with tiny rods of pure gold and coated them with a layer of platinum so thin that it left the gold exposed in some places.
After confirming the structure of the gold-platinum nanorods, Zubarev and Khanal had to find a way to make them soluble in organic solvents that are favored by industry. Building on Zubarev's previous work in making soluble gold nanorods, the pair found a way to attach hair-like molecules of polystyrene to the surface of the gold-platinum rods.
Zubarev and Khanal found the coated particles were easy to remove from solution with a conventional centrifuge. In addition, the polystyrene shells made them completely soluble in organic solvents and dramatically enhanced their catalytic selectivity.
"The selectivity of the coated gold and platinum nanorods will be very attractive to industry," Zubarev said. "For example, we found they had nearly 100 percent catalytic selectivity for the hydrogenation of terminal olefins."
Zubarev's group is using similar methods to produce gold-palladium catalysts in a follow-up study. Palladium is another high-demand catalyst. "The early indications are very promising," he said.
The research is supported by the National Science Foundation, the Robert A. Welch Foundation and the Alfred Sloan Foundation.
Source:
Jade Boyd
Rice University
Visit our biology / biochemistry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/162494.php>
APA
http://www.medicalnewstoday.com/releases/162494.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



